Summary by Futu AI
Carmen Bozic, EVP and CMO of Vertex Pharmaceuticals Inc. (VRTX), completed a sale of 2,280 shares of common stock on June 26, 2024. The transaction was executed at a price of $471.72 per share, resulting in a total sale value of $1,075,521.60. Following the sale, Bozic's direct holdings in the company amount to 30,099 shares of common stock. The sale took place through an open market transaction, as reported in the company's latest filing.